You just read:

Amgen Receives Positive Opinion Expanding Use Of XGEVA® (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe

News provided by

Amgen

Feb 23, 2018, 08:20 ET